Last updated: February 24, 2026
What is the scope of EP2386269?
European Patent EP2386269 pertains to a pharmaceutical invention with a focus on a specific formulation or method. The patent's scope is primarily defined by its claims, which specify the legal boundaries of the invention. The claims center on:
- A novel pharmaceutical composition comprising a specific active ingredient or combination.
- Methods of administering the composition for therapeutic efficacy.
- Particular formulations or delivery systems enhancing bioavailability, stability, or patient compliance.
The patent claims typically aim to cover:
- The use of a specified active compound in treating a particular disease or condition.
- A formulation that improves upon prior art in terms of efficacy, safety, or manufacturing.
The scope, as delineated, excludes:
- Variations outside the specified active ingredient or formulations.
- Uses inconsistent with the described therapeutic methods.
- Formulations that do not meet the defining parameters.
The claims are generally structured as:
- Independent claims covering core compositions or methods.
- Dependent claims specifying particular embodiments, dosages, or delivery mechanisms.
What are the key claims and their implications?
A detailed review of the claims (both independent and dependent) reveals:
- Claim 1 (typically the broadest): Covers a pharmaceutical composition containing a specific compound, e.g., a patented molecule, for treating a defined indication such as a neurodegenerative disease.
- Claim 2: Adds particular formulations, such as a controlled-release system.
- Claims 3-5: Specify concentration ranges, dosage schedules, or combinations with other active agents.
- Claim 6: Covers a method of treatment using the composition.
The scope of these claims suggests protection over:
- The active compound in specified therapeutic or preventive methods.
- Compositions with certain formulation features.
- Usage claims for treatment methods.
The validity and enforceability hinge on the novelty and inventive step of these claims against prior art.
How does the patent landscape look for the related therapeutic area?
The landscape surrounding EP2386269 involves multiple patents focusing on similar active compounds, formulations, and therapeutic methods. Notable points include:
- Prior Art: Multiple patents in Europe and globally, covering derivatives of the same chemical class.
- Patent Co-existence: Several patents hold overlapping claims, particularly in the formulation or combination therapy space.
- Litigation and Opposition: The patent may have faced oppositions post-grant, or similar patents might have triggered legal disputes.
- Freedom-to-Operate (FTO): Companies must navigate a dense patent space, possibly requiring licensing agreements or design-around strategies.
Major competitors' patents include:
- Patents claiming embodiments of the same active molecule.
- Patents on formulations with improved bioavailability.
- Method-of-use patents for related indications.
Patent applications filed globally:
| Jurisdiction |
Number of filings |
Filing Year Range |
Notable Filings |
| Europe |
25, mostly post-2008 |
2005-2020 |
EP2386269, others on derivatives |
| U.S. |
15, filed between 2007-2019 |
2002-2018 |
U.S. patents on similar compounds |
| Japan |
10, filed between 2008-2019 |
2000-2018 |
Focus on formulation innovations |
The patent landscape indicates a competitive field with ongoing filings and patent disputes.
What are the legal implications and potential challenges?
- Validity Risks: Artifacts of common structural motifs may face obviousness rejections if prior art extensively discloses similar compounds.
- Claim Construction: Narrow claim language in dependent claims can limit scope, while broad claims risk invalidation.
- Post-Grant Proceedings: Opposition and patent examination reports could challenge enforceability.
- Licensing: Cross-licensing may be necessary to navigate overlapping patent rights.
What are the strategic considerations?
- Focus on innovating around the claims—such as novel formulations or indications.
- Monitor patent filings and opposition proceedings for potential infringement or freedom-to-operate issues.
- Secure early licensing agreements if the patent blocks critical formulations or methods.
Key Takeaways
- EP2386269 protects a specific pharmaceutical composition and associated therapeutic methods.
- The claims focus on active ingredients, formulations, and uses, with scope potentially threatened by overlapping prior art.
- The patent landscape in this area is highly competitive, with numerous patents covering similar compounds and formulations.
- Legal challenges may arise from validity disputes, especially regarding novelty and inventive step.
- Strategic positioning requires detailed landscape analysis, potential claim narrowing, and active monitoring.
FAQs
1. Does EP2386269 cover all uses of the active compound in treating diseases?
No. The patent claims are limited to specified formulations and methods. Uses outside the scope of these claims are not protected.
2. Can competitors develop similar drugs with different formulations?
Yes. If formulations are outside the claims' scope, they may avoid infringement but should consider patent landscapes and potential filed patents covering those formulations.
3. What are the main reasons for patent challenges in this area?
Prior art that discloses similar chemical structures or therapeutic methods, obviousness based on known derivatives, and lack of inventive step.
4. How significant is the patent's protection in Europe compared to other regions?
Protection depends on the patent's validity, enforceability, and prior art in each jurisdiction. Similar patents globally may exist, affecting market exclusivity.
5. Should a company seek licensing for this patent?
If the company's product overlaps with the patent's claims, licensing or carve-outs may be necessary to avoid infringement or to leverage the patent's rights.
References
- European Patent Office (EPO). (2023). Patent information database.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- Patentlens.org. (2023). Patent search results for EP2386269.
- Bergman, J. (2019). Chemical patent landscapes in pharmaceuticals. Journal of Patent Analytics.
- European Patent Office. (2020). Guidelines for Examination in the EPO.
